Brief: Willow Biosciences Inc - Provides Update On Cannabigerol Research Studies And Key Personnel Appointment
13/01/2021 12:15
Jan 13 (Reuters) - Willow Biosciences Inc WLLW.TO :
* WILLOW BIOSCIENCES INC - PROVIDES UPDATE ON CANNABIGEROL
RESEARCH STUDIES AND KEY PERSONNEL APPOINTMENT
* WILLOW BIOSCIENCES INC - FIRST COMMERCIAL CANNABINOID
SLATED FOR
PRODUCTION IN Q1 2021
Source text for Eikon: ID:nPnbcRZ4Fa
Further company coverage: WLLW.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atlas Energy
See all newsBrief: Atlas Energy Corp. Announces Appointments To Subsidiary Board And Extension Of Tsxv Sandbox Exit Deadline
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Strengthens Leadership Team With Appointment Of Andy Duncan As Senior Executive
Brief: Willow Biosciences Announces Completion Of Transformative Recapitalization Transactions To Form Atlas Energy Corp